Prospective Clinical 5-year Follow-up of the LINK® Endo-Model® SL®
1 other identifier
observational
61
1 country
3
Brief Summary
The objective of this study is to collect outcome information on patients requiring Total Knee Replacement (TKR) in primary or revision cases and therefore receiving the LINK® Endo-Model® SL® under routine conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2017
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2015
CompletedFirst Posted
Study publicly available on registry
February 20, 2015
CompletedStudy Start
First participant enrolled
August 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedJanuary 12, 2023
January 1, 2023
7.1 years
February 12, 2015
January 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
KOOS
Knee Injury and Osteoarthritis Outcome Score
1 yr, 3 yrs and 5 yrs
Secondary Outcomes (4)
Complications
At each Follow-up, up to 5 years
Rate of subsequent surgical interventions
At each Follow-up, up to 5 years
KSS
at 3 months, 1 year and 5 years
Prosthetic Survival Rate
up to 5 years
Eligibility Criteria
All subjects enrolled in the PMCF in compliance with the inclusion/exclusion criteria who signed the Informed Consent Form and received the Endo-Model SL® prosthesis, will be included in the primary and secondary endpoint analysis.
You may qualify if:
- Implantation of the LINK® Endo-Model® SL®.
- Between 18 and 78 years of age.
- Patient has signed the Informed Consent. The indications and contraindications for the implantation of the LINK® Endo-Model® SL® listed in the product catalogue and chapter 2.5 and 2.6 \[of the protocol\] are applicable and have to be considered / fulfilled
You may not qualify if:
- Body Mass Index (BMI) \> 40 kg/m2
- Poor general state of health with a foreseeable life expectancy of less than 5 years
- Knee replacement on the contralateral side within the last year and with a KSS fuctional score \< 70 points
- Comorbidities and known medical circumstances which forseeable affect the clinical functional results after implantation (e.g. neurological or musculoskeletal impairments)
- Revision in floride septic environment
- Female patient who is pregnant
- Prisoner
- Patient who, as judged by the surgeon, is mentally incompetent or is unlikely to be compliant with the prescribed postoperative routine and follow-up evaluation schedule
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Universitätsklinikum Carl Gustav Carus
Dresden, Saxony, 01307, Germany
Medizinische Fakultät Orthopädische Universitätsklinik (KORT)
Magdeburg, Saxony-Anhalt, 39120, Germany
Evangelisches Waldkrankenhaus Spandau
Berlin, 13589, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christoph Lohmann, Prof. Dr.
Medizinische Fakultät Orthopädische Universitätsklinik (KORT), Magdeburg
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2015
First Posted
February 20, 2015
Study Start
August 14, 2017
Primary Completion
September 1, 2024
Study Completion
September 1, 2025
Last Updated
January 12, 2023
Record last verified: 2023-01